Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3786862
Max Phase: Preclinical
Molecular Formula: C11H10N4O
Molecular Weight: 214.23
Molecule Type: Small molecule
Associated Items:
ID: ALA3786862
Max Phase: Preclinical
Molecular Formula: C11H10N4O
Molecular Weight: 214.23
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N#Cc1cnn2c(=O)c3c([nH]c12)CCCC3
Standard InChI: InChI=1S/C11H10N4O/c12-5-7-6-13-15-10(7)14-9-4-2-1-3-8(9)11(15)16/h6,14H,1-4H2
Standard InChI Key: XTTNXYOVGZYVFK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 214.23 | Molecular Weight (Monoisotopic): 214.0855 | AlogP: 0.77 | #Rotatable Bonds: 0 |
Polar Surface Area: 73.95 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.86 | CX Basic pKa: | CX LogP: 1.06 | CX LogD: 1.06 |
Aromatic Rings: 2 | Heavy Atoms: 16 | QED Weighted: 0.70 | Np Likeness Score: -1.63 |
1. McAllister TE, England KS, Hopkinson RJ, Brennan PE, Kawamura A, Schofield CJ.. (2016) Recent Progress in Histone Demethylase Inhibitors., 59 (4): [PMID:26710088] [10.1021/acs.jmedchem.5b01758] |
2. Gehling VS, Bellon SF, Harmange JC, LeBlanc Y, Poy F, Odate S, Buker S, Lan F, Arora S, Williamson KE, Sandy P, Cummings RT, Bailey CM, Bergeron L, Mao W, Gustafson A, Liu Y, VanderPorten E, Audia JE, Trojer P, Albrecht BK.. (2016) Identification of potent, selective KDM5 inhibitors., 26 (17): [PMID:27476424] [10.1016/j.bmcl.2016.07.026] |
Source(1):